T. Rowe Price Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $590K | Buy |
48,201
+755
| +2% | +$9.24K | ﹤0.01% | 2227 |
|
2025
Q1 | $680K | Buy |
47,446
+2,538
| +6% | +$36.4K | ﹤0.01% | 2134 |
|
2024
Q4 | $715K | Sell |
44,908
-20,317
| -31% | -$323K | ﹤0.01% | 2114 |
|
2024
Q3 | $1.57M | Buy |
65,225
+589
| +0.9% | +$14.2K | ﹤0.01% | 1752 |
|
2024
Q2 | $1.29M | Buy |
64,636
+3,738
| +6% | +$74.5K | ﹤0.01% | 1776 |
|
2024
Q1 | $1.21M | Sell |
60,898
-192
| -0.3% | -$3.82K | ﹤0.01% | 1822 |
|
2023
Q4 | $1.37M | Buy |
61,090
+2,581
| +4% | +$57.9K | ﹤0.01% | 1715 |
|
2023
Q3 | $1.18M | Sell |
58,509
-21,558
| -27% | -$436K | ﹤0.01% | 1714 |
|
2023
Q2 | $2.05M | Sell |
80,067
-35,133
| -30% | -$898K | ﹤0.01% | 1465 |
|
2023
Q1 | $3.43M | Sell |
115,200
-11,201
| -9% | -$333K | ﹤0.01% | 1280 |
|
2022
Q4 | $3.42M | Sell |
126,401
-656
| -0.5% | -$17.7K | ﹤0.01% | 1267 |
|
2022
Q3 | $2.77M | Sell |
127,057
-9,657
| -7% | -$210K | ﹤0.01% | 1331 |
|
2022
Q2 | $3.74M | Buy |
136,714
+174
| +0.1% | +$4.76K | ﹤0.01% | 1458 |
|
2022
Q1 | $4.57M | Buy |
136,540
+2,560
| +2% | +$85.8K | ﹤0.01% | 1474 |
|
2021
Q4 | $4.65M | Sell |
133,980
-2,027,116
| -94% | -$70.3M | ﹤0.01% | 1505 |
|
2021
Q3 | $67.4M | Sell |
2,161,096
-314,180
| -13% | -$9.8M | 0.01% | 906 |
|
2021
Q2 | $90M | Sell |
2,475,276
-745,607
| -23% | -$27.1M | 0.01% | 816 |
|
2021
Q1 | $141M | Sell |
3,220,883
-273,699
| -8% | -$12M | 0.01% | 662 |
|
2020
Q4 | $160M | Sell |
3,494,582
-59,345
| -2% | -$2.72M | 0.02% | 582 |
|
2020
Q3 | $118M | Sell |
3,553,927
-498,164
| -12% | -$16.5M | 0.01% | 605 |
|
2020
Q2 | $119M | Sell |
4,052,091
-274,671
| -6% | -$8.07M | 0.02% | 586 |
|
2020
Q1 | $117M | Sell |
4,326,762
-335,327
| -7% | -$9.03M | 0.02% | 530 |
|
2019
Q4 | $157M | Buy |
4,662,089
+106,187
| +2% | +$3.58M | 0.02% | 535 |
|
2019
Q3 | $171M | Sell |
4,555,902
-370,070
| -8% | -$13.9M | 0.02% | 488 |
|
2019
Q2 | $215M | Sell |
4,925,972
-23,466
| -0.5% | -$1.02M | 0.03% | 450 |
|
2019
Q1 | $211M | Sell |
4,949,438
-57,828
| -1% | -$2.47M | 0.03% | 452 |
|
2018
Q4 | $224M | Buy |
5,007,266
+101,538
| +2% | +$4.55M | 0.04% | 407 |
|
2018
Q3 | $336M | Buy |
4,905,728
+41,191
| +0.8% | +$2.82M | 0.05% | 364 |
|
2018
Q2 | $278M | Sell |
4,864,537
-30,311
| -0.6% | -$1.74M | 0.04% | 389 |
|
2018
Q1 | $226M | Sell |
4,894,848
-347,511
| -7% | -$16M | 0.04% | 433 |
|
2017
Q4 | $242M | Sell |
5,242,359
-20,418
| -0.4% | -$943K | 0.04% | 417 |
|
2017
Q3 | $237M | Sell |
5,262,777
-137,111
| -3% | -$6.17M | 0.04% | 412 |
|
2017
Q2 | $212M | Sell |
5,399,888
-227,535
| -4% | -$8.94M | 0.04% | 422 |
|
2017
Q1 | $214M | Sell |
5,627,423
-86,549
| -2% | -$3.3M | 0.04% | 415 |
|
2016
Q4 | $211M | Sell |
5,713,972
-109,196
| -2% | -$4.04M | 0.04% | 415 |
|
2016
Q3 | $202M | Sell |
5,823,168
-91,840
| -2% | -$3.18M | 0.04% | 420 |
|
2016
Q2 | $192M | Buy |
5,915,008
+213,040
| +4% | +$6.93M | 0.04% | 418 |
|
2016
Q1 | $164M | Buy |
5,701,968
+23,025
| +0.4% | +$662K | 0.04% | 437 |
|
2015
Q4 | $190M | Buy |
5,678,943
+1,266,553
| +29% | +$42.3M | 0.04% | 415 |
|
2015
Q3 | $125M | Buy |
4,412,390
+110,630
| +3% | +$3.15M | 0.03% | 518 |
|
2015
Q2 | $174M | Buy |
4,301,760
+962,790
| +29% | +$39M | 0.04% | 477 |
|
2015
Q1 | $164M | Buy |
3,338,970
+149,035
| +5% | +$7.33M | 0.03% | 480 |
|
2014
Q4 | $145M | Buy |
+3,189,935
| New | +$145M | 0.03% | 509 |
|